JOCELYN THOMPSON: Open Payments
NPI 1235853987 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,954 in 181 payments from 23 companies in 2025. Trend: 2023 $1,852 · 2024 $3,020 · 2025 $3,954
Food & beverage: $3,874Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $617 |
| Amgen Inc. | 23 | $386 |
| UCB, Inc. | 20 | $343 |
| Mallinckrodt Hospital Products Inc. | 12 | $317 |
| Janssen Biotech, Inc. | 16 | $305 |
| GlaxoSmithKline, LLC. | 9 | $292 |
| E.R. Squibb & Sons, L.L.C. | 6 | $271 |
| Novartis Pharmaceuticals Corporation | 9 | $241 |
| Lilly USA, LLC | 13 | $222 |
| AstraZeneca Pharmaceuticals LP | 8 | $183 |
Products named: RINVOQ, ACTHAR, Bimzelx, TREMFYA, BENLYSTA, ORENCIA, COSENTYX, TALTZ.
Industry payments across SC — which companies pay providers there.
